Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 19, 2024 11:28 ET | Source: Research and Markets

Asia Pacific Biopharma Excipients Market Research Report 2024-2030: Patent Expiry of Blockbuster Biologics such as Erbitux, Rituxan, Herceptin, Avastin, Aranesp, and Enbrel Fueling Investments

Dublin, Nov. 19, 2024 (GLOBE NEWSWIRE) -- The "Asia Pacific Biopharma Excipients Market Size, Share and Trends Analysis Report by Product (Solubilizers & Surfactants/Emulsifiers, Polyols,...
May 31, 2024 06:46 ET | Source: Research and Markets

Global Biosimilars and Follow-On Biologics Market Report 2024-2034 - Expanding the Portfolio of Biosimilars for Rare Diseases

Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Biosimilars and Follow-On Biologics Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue for the Biosimilars and...
September 21, 2023 07:48 ET | Source: Research and Markets

Unlocking the Potential: Investment in R&D Drives Oncology Biosimilars Growth 2023

Dublin, Sept. 21, 2023 (GLOBE NEWSWIRE) -- The "Oncology Biosimilars Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global oncology biosimilars market...
June 14, 2023 04:33 ET | Source: Research and Markets

Biosimilars and Follow-On Biologics Market Report 2023: Regulatory Hurdles Slowing Down Access to Biosimilars

Dublin, June 14, 2023 (GLOBE NEWSWIRE) -- The "Biosimilars and Follow-On Biologics Market Report 2023-2033" report has been added to ResearchAndMarkets.com's offering.World revenue for the...
November 01, 2022 09:33 ET | Source: Research and Markets

Biosimilars Global Market Report 2022: Production of Insulin Biosimilars Presents Opportunities

Dublin, Nov. 01, 2022 (GLOBE NEWSWIRE) -- The "Biosimilars Global Market Report 2022: By Product, By Types, By Application" report has been added to ResearchAndMarkets.com's offering. The global...
March 22, 2022 05:33 ET | Source: Research and Markets

$3.27 Billion Worldwide Oncology Biosimilars Industry to 2031 - Identify Growth Segments for Investment

Dublin, March 22, 2022 (GLOBE NEWSWIRE) -- The "Oncology Biosimilars Global Market Report 2022: By Drug, By Cancer, By Distribution" report has been added to ResearchAndMarkets.com's offering. This...
February 22, 2022 08:28 ET | Source: Research and Markets

Worldwide Biosimilar Industry to 2027 - Featuring Novartis, Pfizer and Teva Among Others

Dublin, Feb. 22, 2022 (GLOBE NEWSWIRE) -- The "Biosimilar Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's...
August 04, 2021 04:08 ET | Source: Research and Markets

Global Top Selling Biologics Report 2021-2030: Monoclonal Antibody, Hormone, Enzyme, Fusion Protein, Interferon, Gene Therapy

Dublin, Aug. 04, 2021 (GLOBE NEWSWIRE) -- The "Top Selling Biologics Market, 2021-2030: Focus on Product Landscape Assessment, Ongoing Clinical Trials, Promotional Content Analysis, Other Life Cycle...
June 15, 2021 06:18 ET | Source: Research and Markets

Insights on the Biosimilars Global Market to 2025 - Featuring Amgen, Cipla and Pfizer Among Others

Dublin, June 15, 2021 (GLOBE NEWSWIRE) -- The "Global Biosimilars Market 2020-2025" report has been added to ResearchAndMarkets.com's offering. The global biosimilars market should reach $60.1...
June 02, 2021 06:18 ET | Source: Research and Markets

Outlook on the Biosimilar Global Market to 2026 - by Segment, Manufacturer Type, Indication and Region

Dublin, June 02, 2021 (GLOBE NEWSWIRE) -- The "Biosimilar Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's...